Valued at $119.0M at its later-stage round, Nov 2022. Nothing has traded since.
- ·The complete investor list: 13 names
- ·Watch Rgenta Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Rgenta Therapeutics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2021 | Early Stage VC | $8.9M | ▮ | ▮ |
| Jan 2020 | Early Stage VC | $10.0M | ▮ | ▮ |
Membership and data by Private Market View
Rgenta Therapeutics valuation
Rgenta Therapeutics was valued at $119 million at its later-stage round in Nov 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Rgenta Therapeutics raised?
Rgenta Therapeutics has raised $98.9 million in total; 2 of its rounds are on record. The largest on record was an $8.9 million early-stage round in Nov 2021.
Rgenta Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Feb 2022 ($8.9 million sold to 6 investors).
How Rgenta Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Rgenta Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Rgenta Therapeutics
- What is Rgenta Therapeutics worth?
- Rgenta Therapeutics is valued at $119.0M as of Oct 2026. Valued at $119.0M at its later-stage round, Nov 2022. Nothing has traded since.
- How much has Rgenta Therapeutics raised?
- Rgenta Therapeutics has raised $98.9M in total funding across 2 recorded rounds.
- When did Rgenta Therapeutics last raise?
- Rgenta Therapeutics last raised in Nov 2021 (Early Stage VC), raising $8.9M.